Tuesday 21 Oct 2014

Information and opinions presented here do not always represent the views of the American Heart Association.

All posts tagged FDA Safety and Innovation Act

Rose Marie Robertson

FDA hearing highlights research gaps for women, minorities and the elderly

Rose Marie Robertson, M.D., Chief Science Officer of the American Heart Association, testified at a Food and Drug Administration public hearing Tuesday to address gaps in how certain groups of people are represented in research trials used in drug and […]

Continue Reading...